As we turn toward the NASS meeting, it’s a good time to recap spine-related implants and biologics that were granted this designation in 2024.

The division will incorporate Playbook, a surgical workflow and outcome optimization platform designed to enhance surgical planning, collaboration and intraoperative workflow.

Stryker expanded its foot & ankle portfolio with the purchase of 4WEB’s Osteotomy Truss and Ankle Truss systems.

Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.

Vertos Medical has developed mild, a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.

The company will partner with Shalby to conduct a multicenter clinical trial to demonstrate the safety and effectiveness of the mBȏs TKA System.

The acquisition includes OrthoGrid’s fluoroscopy-based Hip AI surgical assistance platform, as well as two additional FDA-cleared orthopedic applications.

ASCs play an increasingly important role in orthopedic companies’ strategies as they seek to capitalize on the growing number of procedures shifting to outpatient settings.

Osteopore will exclusively distribute Zimmer Biomet craniofacial products in the EMEA and APAC regions.

The company is selling all shares of its subsidiaries Olympus Terumo Biomaterials and FH Ortho.